US 7,320,894 B2
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Hasan Kulaksiz, Heidelberg (Germany); Cyril E. Geacintov, Mountainside, N.J. (US); Alfred Janetzko, Butzbach/Nieder-Weisel (Germany); and Wolfgang Stremmel, Heidelberg (Germany)
Assigned to DRG International, Inc., Mountainside, N.J. (US)
Filed on May 19, 2003, as Appl. No. 10/441,089.
Application 10/441089 is a continuation in part of application No. 10/299486, filed on Nov. 19, 2002.
Prior Publication US 2004/0096990 A1, May 20, 2004
Int. Cl. G01N 33/00 (2006.01)
U.S. Cl. 436—86  [435/7.1; 435/975; 436/89; 436/518; 530/300; 530/387.9] 8 Claims
 
1. A kit for detecting a disease condition characterized by non-physiological levels of hepcidin, comprising, an anti-hepcidin antibody or fragment thereof that specifically binds to one or more epitopes of hepcidin located within amino acids 70-84 of SEQ ID NO: 2, and a reagent that binds directly or indirectly to the antibody or fragment thereof.